Lawrence J. Jasinski - May 9, 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Val Gertz
Stock symbol
LMAT
Transactions as of
May 9, 2023
Transactions value $
-$96,275
Form type
4
Date filed
5/11/2023, 04:07 PM
Previous filing
Apr 3, 2023
Next filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $88.7K +2.5K +26.85% $35.48 11.8K May 9, 2023 Direct F1
transaction LMAT Common Stock Options Exercise $55.8K +1.15K +9.72% $48.60 13K May 9, 2023 Direct F1
transaction LMAT Common Stock Sale -$241K -3.65K -28.15% $66.00 9.31K May 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2.5K -100% $0.00* 0 May 9, 2023 Common Stock 2.5K $35.48 Direct F2
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1.15K -33.33% $0.00 2.3K May 9, 2023 Common Stock 1.15K $48.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This option is fully vested and exercisable.
F3 Represents a stock option award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance besting in equal annual installments over the remaining two years.